Google
AORT 株価分析 — ARTIVION INC (Healthcare >> Medical Devices)
AORT に関するよくある質問
AORTのPER（株価収益率）は？
ARTIVION INC（AORT）は現在PER 114.90倍で取引されています。
AORTのROE（自己資本利益率）は？
ARTIVION INCのROEは2.60%です。
AORTの配当利回りは？
ARTIVION INCの配当利回りは0.00%です。
AORTの品質スコア（Quality Score）は？
当社のAIはAORTの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
AORTは今が買い時ですか？
当社AIのタイミングスコアは100点中64点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
AORTはどのセクターに属しますか？
ARTIVION INCはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）
AORT AI Analysis Summary
Our AI summary for AORT: ARTIVION INC (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 114.90, ROE of 2.60%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 64/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 26.83
Price
-0.84
(-3.04%)
Day Change
|
|
|---|
AORT, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
2999
|
| Magic Formula Rank by ROE |
2999
|
| Magic Formula Rank by ROIC |
2820
|
| Price | 26.83 |
| PBV / Sector |
2.98 / -101.57
|
| Earning Per Share | 0.23 |
| PE / Sector |
114.90 / 31.23
|
| PEG or PE/Growth / Sector |
-2.09 / 0.40
|
| Average 1M Daily Value |
11.19 M
GREAT
|
| Average 1W Daily Value |
14.63 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:28 |
| Symbol | AORT |
| Name | ARTIVION INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 48.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,343.19 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1655 Roberts Boulevard NW, Kennesaw, GA, United States, 30144
Phone: 770 419 3355
Website: https://artivion.com
Employees: 1,800
Sector: Healthcare >> Medical Devices
Description: Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
